骶棘韧带子宫固定术或阴道子宫切除联合子宫骶韧带悬吊术后盆腔器官脱垂复发的危险因素
本研究为SAVE-U试验5年随访的二次分析,纳入4所荷兰医院208例子宫脱垂≥2期女性,随机接受骶棘韧带子宫固定术或阴道子宫切除联合子宫骶韧带悬吊术,分析207例年度随访数据,采用广义线性混合模型分析复发事件。结果显示体重指数、吸烟和术前POP-Q Ba点为复合失败结局的显著危险因素。
要点
- 体重指数(每增加1 kg/m²,OR 1.10)、吸烟(OR 2.88)和术前POP-Q Ba点(每增加1 cm,OR 1.23)为复合失败结局的显著危险因素。
- 与骶棘韧带子宫固定术相比,阴道子宫切除是后腔室复发的危险因素(OR 5.21)。
- 吸烟为困扰性阴道膨出症状的危险因素(OR 3.80),术前POP-Q 3或4期对困扰性膨出症状有显著保护作用(OR 0.32)。
核心结论
- 体重指数、吸烟和术前POP-Q Ba点是术后5年内复合失败结局(超出处女膜、困扰性膨出症状、再次手术或使用子宫托)的统计学显著危险因素。
研究设计与样本
- 本研究为SAVE-U试验5年随访的二次分析,该试验在4所荷兰医院开展。
- 共208例子宫脱垂≥2期女性随机接受骶棘韧带子宫固定术或阴道子宫切除联合子宫骶韧带悬吊术,本次分析纳入207例女性的年度5年随访数据。
- 若无缺失值,5年随访期间共将包含1035次测量;复发以「事件」形式采用广义线性混合模型分析,因解剖失败和困扰性阴道膨出症状的复发随时间波动。
主要发现
- 复合失败结局共66例女性发生164次事件;体重指数OR 1.10(每1 kg/m²,95%CI 1.02-1.19,P=.02),吸烟OR 2.88(95%CI 1.12-7.40,P=.03),术前POP-Q Ba点OR 1.23(每1 cm,95%CI 1.01-1.50,P=.04)。
- 整体解剖失败共147例女性发生462次事件;体重指数OR 1.15(95%CI 1.07-1.25,P<.01),术前POP-Q Ba点OR 1.14(95%CI 1.00-1.30,P=.05)。
- 前腔室复发共128例女性发生385次事件;体重指数OR 1.11(95%CI 1.02-1.22,P=.02),术前POP-Q Ba点OR 1.17(95%CI 1.02-1.34,P=.02)。
- 后腔室复发共40例女性发生93次事件;与骶棘韧带子宫固定术相比,阴道子宫切除OR 5.21(95%CI 2.05-13.27,P<.01)。
- 困扰性阴道膨出症状共41例女性发生70次事件;吸烟OR 3.80(95%CI 1.48-9.75,P=.01),术前POP-Q 3或4期OR 0.32(95%CI 0.11-0.89,P=.03)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Given that the number of surgeries for pelvic organ prolapse is expected to increase worldwide, knowledge on risk factors for prolapse recurrence is of importance for developing preventive strategies and shared decision-making. OBJECTIVE: To identify risk factors for subjective and objective failure after either sacrospinous hysteropexy or vaginal hysterectomy with uterosacral ligament suspension over a period of 5 years after surgery. STUDY DESIGN: This was a secondary analysis of the 5-year follow-up of the SAVE-U trial. The SAVE-U trial was conducted in 4 Dutch hospitals. A total of 208 women with uterine prolapse stage ≥2 were randomized to sacrospinous hysteropexy or vaginal hysterectomy with uterosacral ligament suspension. For the current analysis, available annual 5-year follow-up data of 207 women were analyzed. Without missing values this analysis would have included 1035 measurements in total over the 5-year follow-up. Recurrences were analyzed as "events" using generalized linear mixed models because recurrences of anatomic failure and bothersome vaginal bulge symptoms fluctuated over time. The primary outcome was the composite outcome of failure defined as prolapse beyond the hymen, bothersome bulge symptoms, repeated surgery, or pessary use for recurrent prolapse. Secondary outcome measures were bothersome vaginal bulge symptoms, overall anatomic failure (Pelvic Organ Prolapse Quantification stage ≥2 in any compartment), apical compartment recurrence (Pelvic Organ Prolapse Quantification stage ≥2), anterior compartment recurrence (Pelvic Organ Prolapse Quantification stage ≥2), and posterior compartment recurrence (Pelvic Organ Prolapse Quantification stage ≥2). RESULTS: For the composite outcome of failure (164 events in 66 different women), statistically significant risk factors were: body mass index (odds ratio, 1.10 [per 1 kg/m2]; 95% confidence interval, 1.02-1.19; P=.02), smoking (odds ratio, 2.88; 95% confidence interval, 1.12-7.40; P=.03), and preoperative Pelvic Organ Prolapse Quantification point Ba (odds ratio, 1.23 [per 1 cm]; 95% confidence interval, 1.01-1.50; P=.04). When analyzing each surgical outcome measure separately, body mass index and Pelvic Organ Prolapse Quantification point Ba were risk factors for overall anatomic failure (462 events in 147 women; odds ratio, 1.15; 95% confidence interval, 1.07-1.25; P<.01 and odds ratio, 1.14; 95% confidence interval, 1.00-1.30; P=.05, respectively) and anterior compartment recurrence (385 events in 128 women; odds ratio, 1.11; 95% confidence interval, 1.02-1.22; P=.02 and odds ratio, 1.17; 95% confidence interval, 1.02-1.34; P=.02, respectively). Vaginal hysterectomy was a risk factor for posterior compartment recurrence when compared with sacrospinous hysteropexy (93 events in 40 women; odds ratio, 5.21; 95% confidence interval, 2.05-13.27; P<.01). Smoking was a risk factor for bothersome vaginal bulge symptoms (70 events in 41 women; odds ratio, 3.80; 95% confidence interval, 1.48-9.75; P=.01), and preoperative Pelvic Organ Prolapse Quantification stage 3 or 4 was significantly protective against bothersome bulge symptoms (odds ratio, 0.32; 95% confidence interval, 0.11-0.89; P=.03). CONCLUSION: Body mass index, smoking, and Pelvic Organ Prolapse Quantification point Ba were statistically significant risk factors for the composite outcome of failure (prolapse beyond the hymen, bothersome bulge symptoms, repeated surgery, or pessary use for recurrent prolapse) in the period of 5 years after surgery.
引用
- Schulten SF, Detollenaere RJ, IntHout J, et al. Risk factors for pelvic organ prolapse recurrence after sacrospinous hysteropexy or vaginal hysterectomy with uterosacral ligament suspension. Am J Obstet Gynecol. 2022. PMID: 35439530. doi:10.1016/j.ajog.2022.04.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。